Skip to content
Search

Latest Stories

PDA welcomes National Disability Strategy

The Pharmacists' Defence Association (PDA) has welcomed the National Disability Strategy launched by the government which may impact the experience of pharmacists with disabilities.

However, the association believes that there are additional measures that could have been included, such as 'Disability Pay Gap' reporting in the strategy.


PDA also supports the proposal from the Trades Union Congress (TUC) that has called for flexible working arrangements for helping workers manage their health.

The TUC also polled over 2,000 disabled workers in February 2021, looking at their experiences getting reasonable adjustments before and during the pandemic. It found that 4 in 10 disabled workers aren’t getting the reasonable adjustments they need.

The PDA has been supporting pharmacists who have been discriminated against because of disability, and a failure to provide reasonable adjustments is one way in which discrimination can be evidenced.

It encourages all employers to educate their managers about disability and the rights of disabled employees and invites pharmacists who wish to support the work of the Ability Network, whether or not they have a disability, to join here.

PDA Ability Network enables all disabled pharmacists to realise their full potential and raise their profile by being educationally, socially and politically active. The network is one of four Equality, Diversity and Inclusion (EDI) networks at the PDA.

More For You

Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less